EKF Diagnostics Competitors and Similar CompaniesClear all

EKF Diagnostics's competitors and similar companies include Viapath, Binding Site and Meso Scale Diagnostics.

	EKF Diagnostics EKF Diagnostics Holdings is a company that manufactures point-of-care (POCT) devices and tests for hemoglobin, glycated hemoglobin (HbA1c), glucose, and lactate.	Viapath Viapath provides pathology and testing its partners, and NHS and private sector organizations.	Binding Site Binding Site is a company that provides specialist diagnostic products to clinicians and laboratory professionals.	Meso Scale Diagnostics Meso Scale Discovery (MSD) is a company that develops, manufactures, and commercializes assays and instruments.
Founding Date	Founding Date 1990	Founding Date 2009	Founding Date 1983	Founding Date 1995
Type	Type Public	Type Private	Type Private	Type Private
Tags	Tags Healthcare biotech chemicals clinical research distribution medical devices medical diagnostics	Tags Healthcare clinical research genetics hospitals medical diagnostics	Tags Technology biotech clinical research medical diagnostics	Tags Healthcare biotech medical devices medical diagnostics
Locations	Locations Penarth, GB HQ Shanghai, CN Barleben, DE Leipzig, DE Boerne, US Elkhart, US	Locations Bedford, GB HQ London, GB London, GB London, GB London, GB Orpington, GB	Locations Birmingham, GB HQ	Locations Rockville, US HQ
Employees	Employees 303	Employees 2701% decrease	Employees 6681% decrease	Employees 9761% increase
Financial
Revenue (est.)	Revenue (est.) £51.6m (FY, 2025)	Revenue (est.) £122m (FY, 2018)	Revenue (est.) £108.2m (FY, 2021)	Revenue (est.) N/A
Cost of goods	Cost of goods £19.7m (FY, 2025)	Cost of goods £88.9m (FY, 2018)	Cost of goods £32.9m (FY, 2021)	Cost of goods N/A
Gross profit	Gross profit £32.1m (FY, 2025)	Gross profit £33.1m (FY, 2018)	Gross profit £75.3m (FY, 2021)	Gross profit N/A
Net income	Net income £2.5m (FY, 2025)	Net income £2.5m (FY, 2018)	Net income £25.3m (FY, 2021)	Net income N/A